Facebook Linkedin RSS Twitter Youtube
Home 2020

Phase III clinical trials (Clinical trial)

Global Blood Therapeutics CEO Defends Price of Sickle-Cell Drug Oxbryta
Drug Discovery

Global Blood Therapeutics CEO Defends Price of Sickle-Cell Drug Oxbryta

Pfizer Raises Gene Therapy Stake with $500M Sanford, NC, Expansion
Genome Editing

Pfizer Raises Gene Therapy Stake with $500M Sanford, NC, Expansion

Roche, GO Therapeutics to Develop Antibody-Based Cancer Treatments
News

Roche, GO Therapeutics to Develop Antibody-Based Cancer Treatments

Alzheimer’s Amyloid Drug Fails to Slow Cognitive Decline in Clinical Trial
Drug Discovery

Alzheimer’s Amyloid Drug Fails to Slow Cognitive Decline in Clinical Trial

Lupin Acquires Symbiomix Therapeutics for $150M
Industry News

Lupin Acquires Symbiomix Therapeutics for $150M

Anticancer miRNA Coupled to Folate Needs No Protective Packaging
Drug Discovery

Anticancer miRNA Coupled to Folate Needs No Protective Packaging

NightstaRx Raises $45M to Fund Phase III Study with Retinal Disease Gene Therapy
Genome Editing

NightstaRx Raises $45M to Fund Phase III Study with Retinal Disease Gene Therapy

Debiopharm Pays $25M Upfront for ImmunoGen’s Phase II Stage ADC for NHL
Cancer

Debiopharm Pays $25M Upfront for ImmunoGen’s Phase II Stage ADC for NHL

Arsanis Licenses Adimab RSV Antibodies and Wins $9.3M from Bill & Melinda Gates Foundation
Drug Discovery

Arsanis Licenses Adimab RSV Antibodies and Wins $9.3M from Bill & Melinda Gates Foundation

Acacia to File NDA for PONV Drug Following Fourth Phase III Trial Success
Industry News

Acacia to File NDA for PONV Drug Following Fourth Phase III Trial Success

1234...10Page 3 of 10
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.